287 related articles for article (PubMed ID: 26003197)
1. [Pulmonary manifestations of Langerhans cell histiocytosis].
Obert J; Tazi A
Rev Mal Respir; 2015 Oct; 32(8):850-66. PubMed ID: 26003197
[TBL] [Abstract][Full Text] [Related]
2. How I manage pulmonary Langerhans cell histiocytosis.
Lorillon G; Tazi A
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
[TBL] [Abstract][Full Text] [Related]
4. Patchy colitis and interstitial lung disease.
Coronel E; Micic D; Rubin DT
Gastroenterology; 2015 Jan; 148(1):26-7. PubMed ID: 25450070
[No Abstract] [Full Text] [Related]
5. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.
Roden AC; Yi ES
Arch Pathol Lab Med; 2016 Mar; 140(3):230-40. PubMed ID: 26927717
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Langerhans Cell Histiocytosis-associated Pulmonary Hypertension Showing a Drastic Improvement Following Smoking Cessation.
Kinoshita Y; Watanabe K; Sakamoto A; Hidaka K
Intern Med; 2016; 55(5):491-5. PubMed ID: 26935369
[TBL] [Abstract][Full Text] [Related]
7. Rare interstitial lung disease: Pulmonary Langerhans Cell Histiocytosis in a young non smoking Indian female.
Fernandes L; Vadala R; Mesquita AM; Vaideeswar P
Indian J Tuberc; 2015 Jan; 62(1):46-9. PubMed ID: 25857566
[TBL] [Abstract][Full Text] [Related]
8. A Case of Pulmonary Langerhans Cell Histiocytosis with BRAF V600E-negative and MAP2K1-posivtive Mutations Presenting as Diffuse Nodules in Chest High-resolution Computed Tomography After Smoking Cessation.
Li Y; Cai HR; Ma M; Wang LJ; Yang J; Ding JJ; Miao LY
Chin Med J (Engl); 2016 Jun; 129(11):1384-6. PubMed ID: 27231182
[No Abstract] [Full Text] [Related]
9. Pulmonary Langerhans Cell Histiocytosis.
Shaw B; Borchers M; Zander D; Gupta N
Semin Respir Crit Care Med; 2020 Apr; 41(2):269-279. PubMed ID: 32279297
[TBL] [Abstract][Full Text] [Related]
10. Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.
Goyal G; Abeykoon JP; Hu M; Young JR; Shah MV; Bennani NN; Call TG; Hook CC; Pardanani A; Inwards DJ; Vassallo R; Ryu JH; Tobin WO; Koster MJ; Davidge-Pitts CJ; Ravindran A; Rech KL; Go RS;
Am J Hematol; 2021 May; 96(5):E146-E150. PubMed ID: 33539584
[No Abstract] [Full Text] [Related]
11. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
Héritier S; Emile JF; Barkaoui MA; Thomas C; Fraitag S; Boudjemaa S; Renaud F; Moreau A; Peuchmaur M; Chassagne-Clément C; Dijoud F; Rigau V; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Miron J; Jeziorski E; Plat G; Aladjidi N; Ferster A; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Armari-Alla C; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Lescoeur B; Gandemer V; Bodemer C; Lacave R; Hélias-Rodzewicz Z; Taly V; Geissmann F; Donadieu J
J Clin Oncol; 2016 Sep; 34(25):3023-30. PubMed ID: 27382093
[TBL] [Abstract][Full Text] [Related]
12. [A rare interstitital lung disease in two smokers].
Mayer D; Gadient G; Kuhn M
Praxis (Bern 1994); 2010 May; 99(11):671-4. PubMed ID: 20506093
[TBL] [Abstract][Full Text] [Related]
13. Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension.
Fukuda Y; Miura S; Fujimi K; Yano M; Nishikawa H; Yanagisawa J; Hiratsuka M; Shiraishi T; Iwasaki A; Saku K
Eur J Prev Cardiol; 2014 Dec; 21(12):1481-3. PubMed ID: 23897898
[TBL] [Abstract][Full Text] [Related]
14. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis.
Caminati A; Harari S
Proc Am Thorac Soc; 2006 Jun; 3(4):299-306. PubMed ID: 16738193
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary Langerhans cell histiocytosis].
Popper HH
Pathologe; 2015 Sep; 36(5):451-7. PubMed ID: 26289803
[TBL] [Abstract][Full Text] [Related]
16. [Adult pulmonary Langerhans cell histiocytosis].
Lorillon G; Meignin V; Tazi A
Presse Med; 2017 Jan; 46(1):70-78. PubMed ID: 27816342
[TBL] [Abstract][Full Text] [Related]
17. Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung.
DeMartino E; Go RS; Vassallo R
Clin Chest Med; 2016 Sep; 37(3):421-30. PubMed ID: 27514589
[TBL] [Abstract][Full Text] [Related]
18. Adult pulmonary Langerhans' cell histiocytosis.
Tazi A
Eur Respir J; 2006 Jun; 27(6):1272-85. PubMed ID: 16772390
[TBL] [Abstract][Full Text] [Related]
19. Current understanding and management of pulmonary Langerhans cell histiocytosis.
Vassallo R; Harari S; Tazi A
Thorax; 2017 Oct; 72(10):937-945. PubMed ID: 28689173
[TBL] [Abstract][Full Text] [Related]
20. Progress towards molecular-based management of childhood Langerhans cell histiocytosis.
Héritier S; Emile JF; Hélias-Rodzewicz Z; Donadieu J
Arch Pediatr; 2019 Jul; 26(5):301-307. PubMed ID: 31281037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]